EFS according to cytogenetic and molecular response at 3 and 6 mo. (A) EFS by cytogenetic response at 3 mo. (B) EFS by molecular response at 3 mo. (C) EFS by cytogenetic response at 6 mo. (D) EFS by molecular response at 6 mo. Molecular response analysis excludes patients treated with imatinib 400.